FDA Compliance Requirements for Non-Invasive Bone Growth Stimulators
Stay ahead in medical device compliance with this focused training on the FDA’s new rule reclassifying non-invasive bone growth stimulators to class II status, subject to premarket notification and special controls. This course provides detailed guidance on the latest regulatory standards, actionable compliance steps for manufacturers, and essential documentation for FDA submission. Learn how to address performance testing, labeling, software validation, and mitigate risks—including legal and financial consequences for non-compliance—ensuring your device meets all FDA safety and effectiveness expectations.
In this course you will learn the following:
* Understand the scope and intent of the Final Rule for non-invasive bone growth stimulators.
* Identify the key regulatory requirements and classification details.
* Implement the necessary compliance measures, including performance testing, labeling, and risk mitigation.
* Recognize the legal and financial consequences of non-compliance.
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.